Release Date: 21/04/09 11:20 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 120.05KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling